Pfizer, BioNTech Plan Filing as Vaccine Proves 95% Effective

(Bloomberg) -- Pfizer Inc. said a final analysis of clinical-trial data showed its Covid-19 vaccine was 95% effective, paving the way for the company to apply for the first U.S. regulatory authoriz...